2.
Expression of miR-106a in NSCLC patients
| Item | n (%) | Relative miR-106a expression | P |
| Gender | 0.57 | ||
| Male | 62 | 5.16±1.48 | |
| Female | 23 | 4.93±2.00 | |
| Age (years) | 0.31 | ||
| <55 | 31 | 4.81±2.04 | |
| ≥55 | 54 | 5.26±1.93 | |
| Tumor size (cm) | 0.38 | ||
| <3 | 35 | 4.87±2.15 | |
| ≥3 | 50 | 5.26±1.91 | |
| Vascular invasion | 0.83 | ||
| No | 34 | 4.996±1.97 | |
| Yes | 51 | 5.09±2.04 | |
| Lymphatic metastasis | |||
| No | 53 | 4.89±1.98 | 0.18 |
| Yes | 32 | 5.44±1.44 | |
| Differentiation degree | 0.001 | ||
| Well | 10 | 2.95±0.93 | |
| Moderate | 30 | 5.02±1.59 | |
| Poor | 45 | 5.53±2.14 | |
| TNM stages | 0.003
(F: 6.282) |
||
| Stage II | 5 | 3.23±1.28 | |
| Stage Ⅲ | 43 | 4.62±2.05 | |
| Stage Ⅳ | 37 | 5.79±1.75 | |
| Pathological type | 0.14
(F: 2.01) |
||
| Adenocarcinoma | 50 | 4.89±1.91 | |
| Squamous | 17 | 5.90± 2.08 | |
| Others | 18 | 4.69± 2.09 |